[Coren Pharmaceutical: omega-3 triglyceride (2%) medium-long chain fat milk amino acid (16) glucose (36%) injection obtained drug registration approval] June 12, Coren Pharmaceutical announced, the company omega-3 triglyceride (2%) medium-chain fat milk amino acid (16) glucose (36%) injection was approved for drug registration.